Durect Corp (DRRX)
1.31
+0.03
(+2.34%)
USD |
NASDAQ |
Sep 27, 16:00
1.28
-0.03
(-2.29%)
After-Hours: 20:00
Durect Revenue (Annual): 8.548M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.548M |
| December 31, 2022 | 19.28M |
| December 31, 2021 | 13.98M |
| December 31, 2020 | 30.11M |
| December 31, 2019 | 25.07M |
| December 31, 2018 | 15.28M |
| December 31, 2017 | 49.17M |
| December 31, 2016 | 14.02M |
| December 31, 2015 | 19.12M |
| December 31, 2014 | 19.40M |
| December 31, 2013 | 15.33M |
| December 31, 2012 | 53.07M |
| December 31, 2011 | 33.49M |
| Date | Value |
|---|---|
| December 31, 2010 | 31.59M |
| December 31, 2009 | 24.46M |
| December 31, 2008 | 27.10M |
| December 31, 2007 | 30.68M |
| December 31, 2006 | 21.89M |
| December 31, 2005 | 28.57M |
| December 31, 2004 | 13.85M |
| December 31, 2003 | 11.84M |
| December 31, 2002 | 7.185M |
| December 31, 2001 | 6.524M |
| December 31, 2000 | 3.155M |
| December 31, 1999 | 0.086M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
8.548M
Minimum
2023
30.11M
Maximum
2020
19.40M
Average
19.28M
Median
2022
Revenue (Annual) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.854M |
| iBio Inc | 0.225M |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |